Skip to main navigation Skip to search Skip to main content

Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: Prophylactic or preemptive?

Research output: Contribution to journal › Letter › peer-review

Fingerprint

Dive into the research topics of 'Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: Prophylactic or preemptive?'. Together they form a unique fingerprint.
Sort by